New Drugs Effective in the Systemic Treatment of Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

New Drugs Effective in the Systemic Treatment of Hepatocellular Carcinoma

Published:2019-08 Issue:2 Volume:14 Page:56-61
ISSN:2046-2484
Container-title:Clinical Liver Disease
language:en
Short-container-title:Clinical Liver Disease

Author:

Montironi Carla¹²,Montal Robert¹²,Llovet Josep M.¹²³

Affiliation:

1. Liver Cancer Translational Research Laboratory Institut d’Investigacions Biomèdiques August Pi I Sunyer–Hospital Clinic, Liver Unit, Universitat de Barcelona Barcelona Catalonia Spain

2. Mount Sinai Liver Cancer Program, Department of Liver Diseases, Icahn School of Medicine at Mount Sinai New York NY

3. Institució Catalana de Recerca i Estudis Avancats Barcelona Catalonia Spain

Funder

Samuel Waxman Cancer Research Foundation

U.S. Department of Defense

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cld.796

Reference17 articles.

1. Global cancer statistics, 2012

2. Hepatocellular carcinoma

3. Molecular therapies and precision medicine for hepatocellular carcinoma

4. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

5. SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiproliferative Activity of N-Acylhydrazone Derivative on Hepatocellular Carcinoma Cells Involves Transcriptional Regulation of Genes Required for G2/M Transition;Biomedicines;2024-04-18

2. Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin for intermediate and advanced hepatocellular carcinoma: A retrospective study;International Immunopharmacology;2023-12

3. Synergism of small molecules targeting VDAC with sorafenib, regorafenib or lenvatinib on hepatocarcinoma cell proliferation and survival;European Journal of Pharmacology;2023-10

4. Circulating biomarkers for diagnosis and management of hepatocellular carcinoma;World Chinese Journal of Digestology;2023-05-28

5. Ovatodiolide and antrocin synergistically inhibit the stemness and metastatic potential of hepatocellular carcinoma via impairing ribosome biogenesis and modulating ERK/Akt-mTOR signaling axis;Phytomedicine;2023-01